Amphastar Pharmaceuticals, Inc. AMPH
29.06 USD -0.32 (-1.09%)
At closeNov 10, 2026, 7:30 PM EST
29.06 0.00 0.00%
After hours · Nov 10, 7:30 PM ET
28.51 Day range 29.40
16.65 52-week range 31.00
- YTD
- +8.51%
- 1 year
- +11.26%
News
seekingalpha.com Amphastar Pharmaceuticals, Inc. (AMPH) Q3 2026 Earnings Call Transcript Amphastar Pharmaceuticals, Inc. ( AMPH ) Q3 2026 Earnings Call November 5, 2026 5:00 PM EST Company Participants Dan Dischner - Senior Vice President of Human Resources & Corporate Communication…
benzinga.com Wells Fargo Maintains Equal-Weight on Amphastar Pharma, Raises Price Target to $25 Wells Fargo analyst Benjamin Burnett maintains Amphastar Pharma (NASDAQ:AMPH) with a Equal-Weight and raises the price target from $20 to $25.
zacks.com Amphastar (AMPH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates The headline numbers for Amphastar (AMPH) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street…
marketbeat.com Amphastar Pharmaceuticals Q3 Earnings Call Highlights Amphastar Pharmaceuticals NASDAQ: AMPH reported record third-quarter revenue of $207.6 million, up 8% from a year earlier, as sales of BAQSIMI and Primatene MIST and contributions from newer products…
zacks.com Amphastar Pharmaceuticals (AMPH) Tops Q3 Earnings and Revenue Estimates Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $1.14 per share, beating the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.93 per share a year ago.
benzinga.com Amphastar Pharma Q3 Adj. EPS $1.14 Beats $0.86 Estimate, Sales $207.608M Beat $197.852M Estimate Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $1.14 per share which beat the analyst consensus estimate of $0.86 by 32.56 percent. This is a 22.58 percent increase over earnings of…
prnewswire.com Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2026 Net revenues of $207.6 million for the three months ended September 30, 2026 GAAP net income of $37.8 million, or $0.87 per share, for the third quarter Adjusted non-GAAP net income of $49.3 million,…
zacks.com Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for Amphastar (AMPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
prnewswire.com Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 5, 2026 RANCHO CUCAMONGA, Calif., October 29, 2026 /PRNewswire/ -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that the Company will release results for its third quarter of 2026 ended…
zacks.com Should Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the…
defenseworld.net Comparing Enanta Pharmaceuticals (NASDAQ:ENTA) and Amphastar Pharmaceuticals (NASDAQ:AMPH) Amphastar Pharmaceuticals (NASDAQ: AMPH - Get Free Report) and Enanta Pharmaceuticals (NASDAQ: ENTA - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will…
defenseworld.net Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Average Rating of “Reduce” from Analysts Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH - Get Free Report) has been given a consensus recommendation of "Reduce" by the eight analysts that are presently covering the firm, MarketBeat.com…
defenseworld.net Insider Selling: Amphastar Pharmaceuticals (NASDAQ:AMPH) EVP Sells $239,400.00 in Stock Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH - Get Free Report) EVP Rong Zhou sold 10,000 shares of Amphastar Pharmaceuticals stock in a transaction that occurred on Wednesday, September 16th. The…
prnewswire.com Amphastar Pharmaceuticals to Present at the Wells Fargo 21st Annual Healthcare Conference RANCHO CUCAMONGA, Calif., Sept. 1, 2026 /PRNewswire/ -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, and Tony Marrs, EVP of Regulatory Affairs and Clinical…
zacks.com 3 Generic Drug Stocks to Watch Amid Improving Industry Trends The Medical - Generic Drugs industry gains from new launches, biosimilar momentum and portfolio shifts, despite pricing pressure and supply challenges.
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Autonomix Medical (NASDAQ:AMIX) stock moved upwards by 142.1% to $13.0 during Monday's after-market session. The company's market cap stands at $5.1 million. Picard Medical (AMEX:PMI) stock…
zacks.com New Strong Sell Stocks for August 14th AMPH, CHT and HE have been added to the Zacks Rank #5 (Strong Sell) List on August 14, 2026.
benzinga.com Piper Sandler Maintains Neutral on Amphastar Pharma, Lowers Price Target to $20 Piper Sandler analyst David Amsellem maintains Amphastar Pharma (NASDAQ:AMPH) with a Neutral and lowers the price target from $21 to $20.
benzinga.com Wells Fargo Maintains Equal-Weight on Amphastar Pharma, Raises Price Target to $20 Wells Fargo analyst Benjamin Burnett maintains Amphastar Pharma (NASDAQ:AMPH) with a Equal-Weight and raises the price target from $19 to $20.
seekingalpha.com Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2026 Earnings Call Transcript Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2026 Earnings Call Transcript
zacks.com Compared to Estimates, Amphastar (AMPH) Q2 Earnings: A Look at Key Metrics Although the revenue and EPS for Amphastar (AMPH) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall…
marketbeat.com Amphastar Pharmaceuticals Q2 Earnings Call Highlights Amphastar Pharmaceuticals NASDAQ: AMPH reported second-quarter 2026 revenue growth, supported by recently launched products including ipratropium bromide inhalation, while management said it is…- benzinga.com Amphastar Pharma Q2 Adj. EPS $0.91 Beats $0.62 Estimate, Sales $183.903M Beat $182.055M Estimate Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $0.91 per share which beat the analyst consensus estimate of $0.62 by 46.77 percent. This is a 7.06 percent increase over earnings of…
prnewswire.com Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026 Net revenues of $183.9 million for the three months ended June 30, 2026 GAAP net income of $30.3 million, or $0.67 per share, for the second quarter Adjusted non-GAAP net income of $40.8 million, or…
prnewswire.com Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026 RANCHO CUCAMONGA, Calif., July 29, 2026 /PRNewswire/ -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that the Company will release results for its second quarter of 2026 ended June…
benzinga.com Two Years to Build or Pay 200% — Which US Pharma Stocks Win? Trump sets a 2-year ultimatum for generic drugmakers to reshore U.S. production or face tariffs up to 200%.
cnbc.com Trump's generic drug tariffs: What they could mean for medicine prices, manufacturers and supply Trump plans tariffs of up to 200% on imported generic drugs after a two-year grace period aimed at encouraging U.S. manufacturing. But thin profit margins make tariffs harder to absorb than for…
benzinga.com Amphastar Pharmaceuticals Unit International Medication Systems Receives FDA Warning Letter Regarding Violations Of Current Good Manufacturing Practice At IMS's Drug Manufacturing Facility In California On July 2, 2026, International Medication Systems, Limited ("IMS"), a subsidiary of the Company, received a warning letter (the "Warning Letter") from the FDA relating to IMS's drug manufacturing
benzinga.com Crude Oil Gains 2%; Comcast Shares Spike Higher U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 200 points on Monday. The Dow traded up 0.44% to 52,105.66 while the NASDAQ rose 1.33% to 25,634.54. The…
benzinga.com This Liquidia Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday Top Wall Street analysts changed outlook on top stocks. See all changes including upgrades, downgrades, and initiations on analyst ratings page.
benzinga.com This Whirlpool Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday Analysts downgraded DOCS, MWH, WHR, AMPH, and WIX and lowered price targets. See how analysts view these stocks. Considering WHR stock? See analyst opinions.
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session 
benzinga.com This HubSpot Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday Wall Street analysts changed outlook on top names. Check all changes on analyst ratings page. See what analysts think about HUBS stock.
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session 
benzinga.com Flutter Entertainment Posts Downbeat Q4 Results, Joins Zscaler, Elastic And Other Big Stocks Moving Lower In Friday's Pre-Market Session (CORRECTED) 
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session 
benzinga.com Why Applied Optoelectronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket 
benzinga.com Earnings Scheduled For February 26, 2026 
benzinga.com Earnings Scheduled For November 6, 2025 
benzinga.com Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs The Trump administration backs off plans to impose tariffs on generic drugs after internal debate over price impacts and supply concerns.
benzinga.com Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum FDA approves Amphastar's iron sucrose injection for CKD-associated anemia, with potential for $80-100 million sales and a 2025 launch.- benzinga.com Earnings Scheduled For August 7, 2025
benzinga.com This Target Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday - benzinga.com Earnings Scheduled For May 7, 2025
- benzinga.com Earnings Scheduled For February 27, 2025
benzinga.com Earnings Scheduled For February 28, 2024 Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion.- benzinga.com Disney, Twilio, TransDigm, Marathon Digital And Other Big Stocks Moving Higher On Thursday U.S. stocks traded mostly lower, with the Dow Jones falling around 75 points on Thursday. Here are some big stocks recording gains in today’s session.
- benzinga.com Earnings Scheduled For November 8, 2023 Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.
- benzinga.com Earnings Scheduled For August 8, 2023 Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly earnings at $0.21 per share on revenue of $1.48 billion.
- benzinga.com Earnings Scheduled For May 9, 2023 Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million.